Rainforest Distribution Corp. has implemented Samsara Route Planning and Commercial Navigation across its direct-store-delivery fleet, unifying routing, navigation, telematics, and compliance on one platform integrated with its SAP system. This upgrade supports Rainforest's multi-year investment in technology and infrastructure, enhancing route optimization and operational control for its temperature-controlled distribution network serving over 4,000 retailers in 22 states. The integration allows real-time tracking, improved route planning considering vehicle specifics, and streamlined driver operations via a single app. This move strengthens Rainforest's ability to deliver high-touch perishables and custom retail programs efficiently at national chain service levels.
Rainforest Distribution's expansion of routing capabilities comes as the Consumer Staples sector on Pluang showed limited gains, with only 6 of 63 stocks rising as of Nov 06, 2026 19:12 WIB. Notable movers included TAL Education Group at USD 9.80 with a 1-day change of -3.83%, British American Tobacco at USD 60.68 down 3.80%, and Unilever at USD 65.56 down 3.18%. This data provides a snapshot of market activity within the sector on the platform.
Kendal Nutricare Limited will be referred to government and state agencies after refusing to participate in a compliance inquiry by the BBB National Programs’ National Advertising Division. The inquiry followed a challenge by Abbott Laboratories rega...
The Mexico animal healthcare market is projected to grow from $2.13 billion in 2025 to $3.34 billion by 2031, at a CAGR of 7.84%. Growth is fueled by rising spending on companion animals, expanding livestock production, and innovations in veterinary ...
BriaCell Therapeutics and its subsidiary BriaPro presented positive preclinical data at the SITC 2026 Annual Meeting, highlighting their immunotherapy platforms Bria-OTS+ and BP-80. Bria-OTS+ showed broad immune activation and sustained cancer cell k...
Canary Capital has launched the Canary Staked INJ ETF (INJC) on Nasdaq, providing investors exposure to INJ, the native token of the Injective blockchain. The ETF not only tracks INJ's price but also earns staking rewards from the network's proof-of-...
IMUNON, Inc. presented new data from its Phase 2 OVATION 2 trial showing that IMNN-001, combined with chemotherapy, significantly enhances anti-tumor T-cell immune responses in advanced ovarian cancer patients. This immune activation correlates with ...
